Camilla Thellenberg Karlsson

Research qualifications: Docent

Contact

Works as

Adjunct associate professor at Department of Diagnostics and Intervention Section: Oncology

27C, Målpunkt QC31, NUS, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Management of patients with advanced prostate cancer. Report from the 2024 advanced prostate cancer consensus conference (APCCC)

European Urology, Elsevier 2025, Vol. 87, (2) : 157-216

Gillessen, Silke; Turco, Fabio; Davis, Ian D.; et al.

Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI: a comparative study

EJNMMI Research, Springer Nature 2025, Vol. 15, (1)

Grefve, Josefine; Strandberg, Sara; Jonsson, Joakim; et al.

Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis

Clinical and Experimental Metastasis, Springer Nature 2025, Vol. 42, (5)

Halin Bergström, Sofia; Semenas, Julius; Nordstrand, Annika; et al.

Adjuvant docetaxel versus surveillance in intermediate- or high-risk prostate cancer after radical curative radiotherapy: final survival results from the SPCG-13 trial

European Urology Oncology, Elsevier 2025, Vol. 8, (4) : 999-1002

Kellokumpu-Lehtinen, Pirkko-Liisa; Fransson, Ann-Sofie; Marttila, Timo; et al.

Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference

Acta Oncologica, MJS Publishing 2025, Vol. 64 : 1482-1488

Nilsson, Erik; Nilsson, Anneli; Jonsson, Joakim; et al.

Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

BJU International

Zaurito, Paolo; Westerberg, Marcus; Garmo, Hans; et al.

Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging

Physics and Imaging in Radiation Oncology, Elsevier 2024, Vol. 31

Grefve, Josefine; Söderkvist, Karin; Gunnlaugsson, Adalsteinn; et al.

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

International Journal of Cancer, John Wiley & Sons 2024, Vol. 155, (4) : 637-645

Strömberg, Ulf; Berglund, Anders; Carlsson, Stefan; et al.

Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer

Acta Oncologica, MJS Publishing, Medical Journals Sweden 2024, Vol. 63 : 503-510

Zarei, Maryam; Wallstén, Elin; Grefve, Josefine; et al.

Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

Radiation Oncology, BioMed Central (BMC) 2023, Vol. 18, (1)

Björeland, Ulrika; Notstam, Kristina; Fransson, Per; et al.

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 93-100

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; et al.

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

Communications Medicine, Springer Nature 2023, Vol. 3, (1)

Nilsson, Erik; Sandgren, Kristina; Grefve, Josefine; et al.

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [⁶⁸Ga]PSMA-11-PET and [¹¹C]Acetate-PET

Nuclear medicine communications, Lippincott Williams & Wilkins 2023, Vol. 44, (11) : 997-1004

Sandgren, Kristina; Strandberg, Sara; Jonsson, Joakim; et al.

Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer

Acta Oncologica, Taylor & Francis 2023, Vol. 6212 : 1698-1706

Spyratou, Vasiliki; Freyhult, Eva; Bergh, Anders; et al.

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

European Journal of Cancer, Elsevier 2023, Vol. 181 : 198-207

Thellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; et al.

Risk of severe late toxicity after radiotherapy following radical prostatectomy: a nationwide study

BJU International, John Wiley & Sons 2022, Vol. 130, (6) : 799-808

Braide, Karin; Kindblom, Jon; Thellenberg-Karlsson, Camilla; et al.

The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (4) : 278-284

Bratt, Ola; Carlsson, Stefan; Fransson, Per; et al.

The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (4) : 265-273

Bratt, Ola; Carlsson, Stefan; Fransson, Per; et al.

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Acta Oncologica, Taylor & Francis 2022, Vol. 61, (3) : 328-332

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; et al.

Characteristics of patients in SPCG-15: a randomized trial comparing radical prostatectomy with primary radiotherapy plus androgen deprivation therapy in men with locally advanced prostate cancer

European Urology Open Science, Elsevier BV 2022, Vol. 41 : 63-73

Gongora, Magdalena; Stranne, Johan; Johansson, Eva; et al.

Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C

Molecular Oncology, John Wiley & Sons 2022, (4)

Thysell, Elin; Köhn, Linda; Semenas, Julius; et al.

Epithelial and stromal characteristics of primary tumors predict the bone metastatic subtype of prostate cancer and patient survival after androgen-deprivation therapy

Cancers, MDPI 2022, Vol. 14, (21)

Wikström, Pernilla; Halin Bergström, Sofia; Josefsson, Andreas; et al.

Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy

Physics and Imaging in Radiation Oncology, Elsevier 2021, Vol. 17 : 117-123

Björeland, Ulrika; Nyholm, Tufve; Jonsson, Joakim; et al.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

The Lancet Oncology, Elsevier 2021, Vol. 22, (2) : 235-245

Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; et al.

Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings: what is the potential to increase the tumor control probability?

Acta Oncologica, Taylor & Francis 2021, Vol. 60, (2) : 199-209

Gronlund, Eric; Almhagen, Erik; Johansson, Silvia; et al.

Deep learning-based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy

Journal of Applied Clinical Medical Physics, John Wiley & Sons 2021, Vol. 22, (12) : 51-63

Jamtheim Gustafsson, Christian; Lempart, Michael; Swärd, Johan; et al.

Registration of histopathology to magnetic resonance imaging of prostate cancer

Physics and Imaging in Radiation Oncology, Elsevier 2021, Vol. 18 : 19-25

Sandgren, Kristina; Nilsson, Erik; Keeratijarut Lindberg, Angsana; et al.

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Trials, BioMed Central 2021, Vol. 22, (1)

Welén, Karin; Överby, Anna K.; Ahlm, Clas; et al.

High monocyte count and expression of s100a9 and s100a12 in peripheral blood mononuclear cells are associated with poor outcome in patients with metastatic prostate cancer

Cancers, MDPI 2021, Vol. 13, (10)

Åberg, Anna-Maja; Halin Bergström, Sofia; Thysell, Elin; et al.

Assessing Radiographic Response to ²²³Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients

Journal of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging 2020, Vol. 61, (5) : 671-675

Anand, Aseem; Tragardh, Elin; Edenbrandt, Lars; et al.

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens

The Prostate, John Wiley & Sons 2020, Vol. 80, (2) : 214-224

Bovinder Ylitalo, Erik; Thysell, Elin; Thellenberg-Karlsson, Camilla; et al.

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Trials, BioMed Central 2020, Vol. 21, (1)

Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; et al.

A randomized phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy (RT) for intermediate and high-risk prostate cancer (PC): Quality-of-life results (QoL) in SPCG-13 trial

Journal of Clinical Oncology, American Society of Clinical Oncology 2020, Vol. 38, (6)

Kellokumpu-Lehtinen, Pirkko-Liisa; Hjälm-Eriksson, Marie; Thellenberg-Karlsson, Camilla; et al.

Tumor-educated platelets for early prostate cancer diagnosis, and therapy stratification in patients with metastasized castration resistant prostate cancer

Clinical Cancer Research, American Association for Cancer Research 2020, Vol. 26, (11) : 73-74

Tjon-Kon-Fat, Lee-Ann; Köhn, Linda; Best, Myron; et al.

Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images

EJNMMI Physics, Springer 2020, Vol. 7, (1)

Wallstén, Elin; Axelsson, Jan; Jonsson, Joakim; et al.

Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

International Brazilian Journal of Urology, Vol. 46, (6) : 1100-1101

Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.

Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy: A Systematic Review

European Urology Focus, Elsevier 2019, Vol. 5, (4) : 550-560

Sandgren, Kristina; Westerlinck, Philippe; Jonsson, Joakim; et al.

Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases

The Prostate, Wiley Periodicals 2019, Vol. 79, (14) : 1683-1691

Sartor, Oliver; Heinrich, Daniel; Mariados, Neil; et al.

PET/MRI attenuation correction in the pelvic region with a statistical decomposition method

European Journal of Nuclear Medicine and Molecular Imaging, Springer 2019, Vol. 46, (SUPPL 1) : S289-S290

Wallstén, Elin; Axelsson, Jan; Jonsson, Joakim; et al.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet, Elsevier 2019, Vol. 394, (10196) : 385-395

Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.

Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2018, Vol. 100, (2) : 317-324

Adjeiwaah, Mary; Bylund, Mikael; Lundman, Josef A.; et al.

Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT

Journal of radiation oncology, Springer 2018, Vol. 7, (4) : 357-366

Björeland, Ulrika; Jonsson, Joakim; Alm, Magnus; et al.

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden

Acta Oncologica, Taylor & Francis 2018, Vol. 57, (2) : 187-194

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; et al.

Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients

Acta Oncologica, Vol. 57, (5) : 574-581

Gronlund, Eric; Johansson, Silvia; Nyholm, Tufve; et al.

Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients

The Prostate, Wiley-Blackwell 2018, Vol. 78, (1) : 48-53

Tjon-Kon-Fat, Lee-Ann; Lundholm, Marie; Schröder, Mona; et al.

Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial

Radiotherapy and Oncology, Elsevier 2018, Vol. 127 : S314-S314

Widmark, Anders; Gunnlaugsson, A.; Beckman, Lars; et al.

Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A randomized, open label, phase III, multicenter trial

Annals of Oncology, Elsevier 2017, Vol. 28, (S5) : v281-v281

Andren, O.; Widmark, Anders; Falt, A.; et al.

Haralick texture features from apparent diffusion coefficient (ADC) MRI images depend on imaging and pre-processing parameters

Scientific Reports, Nature Publishing Group 2017, Vol. 7

Brynolfsson, Patrik; Nilsson, David; Torheim, Turid; et al.

Patient-induced susceptibility effects simulation in magnetic resonance imaging

Physics and Imaging in Radiation Oncology, Elsevier 2017, Vol. 1 : 41-45

Lundman, Josef Axel; Bylund, Mikael; Garpebring, Anders; et al.

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Annals of Oncology, OXFORD UNIV PRESS 2017, Vol. 28, (10) : 2464-2471

Sartor, O.; Heinrich, D.; Mariados, N.; et al.

View publications in DiVA

Research groups

Group member

Per Fransson lab

Research projects

1 September 2023

SPRINTR project

1 January 2022

PAMP (PSMA, Acetate and Multiparametric MRI for Prostate cancer)